Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcus Groettrup

Showing results (81-90 of 135) with videos related to

Pageof 14
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|July 9, 2005
Cross-presentation of the long-lived lymphocytic choriomeningitis virus nucleoprotein does not require neosynthesis and is enhanced via heat shock proteinsSameh Basta, Ricarda Stoessel, Michael Basler, et al.
Journal of Cell Science|October 2, 2014
The ubiquitin-like modifier FAT10 decorates autophagy-targeted Salmonella and contributes to Salmonella resistance in miceValentina Spinnenhirn, Hesso Farhan, Michael Basler, et al.
The Prostate|December 31, 2015
The STEAP1(262-270) peptide encapsulated into PLGA microspheres elicits strong cytotoxic T cell immunity in HLA-A*0201 transgenic mice--A new approach to immunotherapy against prostate carcinomaValerie L Herrmann, Daniel E Wieland, Daniel F Legler, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 25, 2015
The Ubiquitin-like Modifier FAT10 Is Selectively Expressed in Medullary Thymic Epithelial Cells and Modifies T Cell SelectionStefanie Buerger, Valerie L Herrmann, Sarah Mundt, et al.
Kidney International|December 13, 2017
Immunoproteasome inhibition prevents chronic antibody-mediated allograft rejection in renal transplantationJun Li, Michael Basler, Gerardo Alvarez, et al.
Cell Reports|March 17, 2021
Parkin is an E3 ligase for the ubiquitin-like modifier FAT10, which inhibits Parkin activation and mitophagyNicola D Roverato, Carolin Sailer, Nicola Catone, et al.
Kidney International|January 28, 2019
Immunoproteasome inhibition induces plasma cell apoptosis and preserves kidney allografts by activating the unfolded protein response and suppressing plasma cell survival factorsJun Li, Julia Koerner, Michael Basler, et al.
Immunogenetics|March 7, 2018
The expression profile of the ubiquitin-like modifier FAT10 in immune cells suggests cell type-specific functionsRichard Schregle, Mei Min Mah, Stefanie Mueller, et al.
Blood|November 26, 2008
Prostaglandin E(2) enhances T-cell proliferation by inducing the costimulatory molecules OX40L, CD70, and 4-1BBL on dendritic cellsPetra Krause, Markus Bruckner, Christina Uermösi, et al.
Cell|March 5, 2013
Immuno- and constitutive proteasomes do not differ in their abilities to degrade ubiquitinated proteinsJames A Nathan, Valentina Spinnenhirn, Gunter Schmidtke, et al.
Pageof 14

Showing results (81-90 of 135) with videos related to

Sort By:
Pageof 14
Journal of Immunology (Baltimore, Md. : 1950)|July 9, 2005
Cross-presentation of the long-lived lymphocytic choriomeningitis virus nucleoprotein does not require neosynthesis and is enhanced via heat shock proteinsSameh Basta, Ricarda Stoessel, Michael Basler, et al.
Journal of Cell Science|October 2, 2014
The ubiquitin-like modifier FAT10 decorates autophagy-targeted Salmonella and contributes to Salmonella resistance in miceValentina Spinnenhirn, Hesso Farhan, Michael Basler, et al.
The Prostate|December 31, 2015
The STEAP1(262-270) peptide encapsulated into PLGA microspheres elicits strong cytotoxic T cell immunity in HLA-A*0201 transgenic mice--A new approach to immunotherapy against prostate carcinomaValerie L Herrmann, Daniel E Wieland, Daniel F Legler, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 25, 2015
The Ubiquitin-like Modifier FAT10 Is Selectively Expressed in Medullary Thymic Epithelial Cells and Modifies T Cell SelectionStefanie Buerger, Valerie L Herrmann, Sarah Mundt, et al.
Kidney International|December 13, 2017
Immunoproteasome inhibition prevents chronic antibody-mediated allograft rejection in renal transplantationJun Li, Michael Basler, Gerardo Alvarez, et al.
Cell Reports|March 17, 2021
Parkin is an E3 ligase for the ubiquitin-like modifier FAT10, which inhibits Parkin activation and mitophagyNicola D Roverato, Carolin Sailer, Nicola Catone, et al.
Kidney International|January 28, 2019
Immunoproteasome inhibition induces plasma cell apoptosis and preserves kidney allografts by activating the unfolded protein response and suppressing plasma cell survival factorsJun Li, Julia Koerner, Michael Basler, et al.
Immunogenetics|March 7, 2018
The expression profile of the ubiquitin-like modifier FAT10 in immune cells suggests cell type-specific functionsRichard Schregle, Mei Min Mah, Stefanie Mueller, et al.
Blood|November 26, 2008
Prostaglandin E(2) enhances T-cell proliferation by inducing the costimulatory molecules OX40L, CD70, and 4-1BBL on dendritic cellsPetra Krause, Markus Bruckner, Christina Uermösi, et al.
Cell|March 5, 2013
Immuno- and constitutive proteasomes do not differ in their abilities to degrade ubiquitinated proteinsJames A Nathan, Valentina Spinnenhirn, Gunter Schmidtke, et al.
Pageof 14